Request Trial
16 July 2024NewsCareersMarisa Woutersen

Polsinelli expands Hatch-Waxman and litigation practices

Firm adds new chair of Hatch-Waxman & Biologics Practice is an FDA and pharma litigation expert who will ‘provide clarity in an uncertain post-Chevron world’ | Shareholder brings extensive trial and appellate experience in automotive industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Blank Rome adds to growing team with patent agent from MBHB
14 May 2026   The biotechnology and life sciences specialist joins from McDonnell Boehnen Hulbert & Berghoff, marking the fifth senior IP hire at the firm this year.
Careers
Kilpatrick adds tech patent litigator and China expert to Chicago office
6 May 2026   The new partner, a former entrepreneur and self-proclaimed ‘hardcore programmer’, brings patent litigation savvy to the firm.
Careers
Squire Patton Boggs promotes partner to head Europe IP&T practice
1 May 2026   The IP expert will use his new role to support clients in cross-border challenges driven by innovation, digitalisation, market pressure and regulatory change.


Editor's picks

Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

Editor's picks

Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026

More features

Lupin scores another win in kidney drug dispute
Battle over inhaler shape ends badly for Boehringer
Chinese medtech company fined by UPC over injunction breaches
Healthcare leads sweeping AI partnership in Singapore
Jones Day adds in-house biologics specialist to Boston office
Kirkland & Ellis subject of alleged conflict in trade secrets clash
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
Orrick lands five-member M&A team in Paris